William S Marth Insider Trading $AMRI ALBANY MOLECULAR RESEARCH INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for William S Marth.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of William S Marth. William S Marth is Director in Teligent, Inc. ($TLGT) and Director in ALBANY MOLECULAR RESEARCH INC ($AMRI) and President and CEO in ALBANY MOLECULAR RESEARCH INC ($AMRI) and Director in Sorrento Therapeutics, Inc. ($SRNE).
William S Marth in ALBANY MOLECULAR RESEARCH INC
Trading Symbol: AMRIIndustry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of William S Marth: President and CEO, Director
Holdings: 503,416 shares
Current Value: $9,282,991
Latest Transaction: Sep 05 2017
$AMRI Market Capitalization: $765.67M
$AMRI Previous Close: $18.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of William S Marth in ALBANY MOLECULAR RESEARCH INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AMRI, SRNE, TLGT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Option Exercise | D | 18.41 | 133,690 | 2,461,233 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Option Exercise | D | 15.77 | 54,498 | 859,433 | 0 | |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Sell | D | 21.75 | 483,033 | 10,505,968 | 0 | 483 K to 0 (-100.00 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Sell | J | 0.00 | 20,383 | 0 | 483,033 | 503.4 K to 483 K (-4.05 %) |
Sep 05 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Sell | J | 0.00 | 18,472 | 0 | 503,416 | 521.9 K to 503.4 K (-3.54 %) |
Jul 06 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 16.04 | 884 | 14,179 | 521,888 | 521 K to 521.9 K (+0.17 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Option Exercise | A | 18.41 | 133,690 | 2,461,233 | 133,690 | |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 0.00 | 20,383 | 0 | 521,004 | 500.6 K to 521 K (+4.07 %) |
Feb 10 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 0.00 | 27,159 | 0 | 500,621 | 473.5 K to 500.6 K (+5.74 %) |
Feb 07 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Payment of Exercise | F | 18.52 | 1,942 | 35,966 | 473,462 | 475.4 K to 473.5 K (-0.41 %) |
Feb 07 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Payment of Exercise | F | 18.52 | 41,626 | 770,914 | 475,404 | 517 K to 475.4 K (-8.05 %) |
Jan 03 2017 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Payment of Exercise | F | 18.63 | 8,425 | 156,958 | 517,030 | 525.5 K to 517 K (-1.60 %) |
Jul 07 2016 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 11.42 | 1,312 | 14,983 | 525,455 | 524.1 K to 525.5 K (+0.25 %) |
May 16 2016 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Buy | P | 12.86 | 12,500 | 160,750 | 524,143 | 511.6 K to 524.1 K (+2.44 %) |
Feb 08 2016 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Option Exercise | A | 15.77 | 54,498 | 859,433 | 54,498 | |
Feb 08 2016 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 16.79 | 490 | 8,227 | 510,668 | 510.2 K to 510.7 K (+0.10 %) |
Feb 08 2016 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 15.77 | 71,338 | 1,125,000 | 510,178 | 438.8 K to 510.2 K (+16.26 %) |
Jan 04 2016 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Payment of Exercise | F | 20.16 | 8,374 | 168,820 | 438,840 | 447.2 K to 438.8 K (-1.87 %) |
Jun 08 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Buy | P | 19.98 | 10,000 | 199,800 | 447,214 | 437.2 K to 447.2 K (+2.29 %) |
Apr 08 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Option Exercise | M | 5.99 | 12,367 | 74,078 | 0 | |
Apr 08 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Option Exercise | M | 2.59 | 10,000 | 25,900 | 0 | |
Apr 08 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Buy | M | 5.99 | 12,367 | 74,078 | 437,214 | 424.8 K to 437.2 K (+2.91 %) |
Apr 08 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Buy | M | 2.59 | 10,000 | 25,900 | 424,847 | 414.8 K to 424.8 K (+2.41 %) |
Mar 06 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Buy | P | 17.70 | 20,000 | 354,000 | 414,847 | 394.8 K to 414.8 K (+5.07 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 13.84 | 940 | 13,010 | 394,847 | 393.9 K to 394.8 K (+0.24 %) |
Mar 04 2015 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 17.05 | 58,651 | 1,000,000 | 393,907 | 335.3 K to 393.9 K (+17.49 %) |
Jan 03 2014 | AMRI | ALBANY MOLECULAR R ... | Marth William S | President and CEO | Grant | A | 10.08 | 99,207 | 1,000,007 | 190,366 | 91.2 K to 190.4 K (+108.83 %) |
Dec 04 2013 | AMRI | ALBANY MOLECULAR R ... | Marth William S | Director | Buy | P | 10.75 | 30,000 | 322,500 | 91,159 | 61.2 K to 91.2 K (+49.05 %) |
Nov 22 2013 | AMRI | ALBANY MOLECULAR R ... | Marth William S | Director | Buy | P | 11.57 | 20,000 | 231,400 | 61,159 | 41.2 K to 61.2 K (+48.59 %) |
Jun 06 2013 | AMRI | ALBANY MOLECULAR R ... | Marth William S | Director | Grant | A | 10.46 | 2,868 | 29,999 | 41,159 | 38.3 K to 41.2 K (+7.49 %) |
Jun 04 2013 | AMRI | ALBANY MOLECULAR R ... | Marth William S | Director | Buy | P | 10.23 | 10,000 | 102,300 | 38,291 | 28.3 K to 38.3 K (+35.35 %) |
Feb 04 2013 | AMRI | ALBANY MOLECULAR R ... | Marth William S | Director | Option Exercise | A | 5.99 | 12,367 | 74,078 | 12,367 | |
Feb 04 2013 | AMRI | ALBANY MOLECULAR R ... | Marth William S | Director | Grant | A | 5.99 | 5,843 | 35,000 | 28,291 | 22.4 K to 28.3 K (+26.03 %) |
Dec 04 2012 | AMRI | ALBANY MOLECULAR R ... | Marth William S | Director | Buy | P | 5.00 | 10,000 | 50,000 | 22,448 | 12.4 K to 22.4 K (+80.33 %) |
Jun 14 2012 | AMRI | ALBANY MOLECULAR R ... | Marth William S | Director | Option Exercise | A | 2.59 | 10,000 | 25,900 | 10,000 | |
Jun 07 2012 | AMRI | ALBANY MOLECULAR R ... | Marth William S | Director | Grant | A | 2.41 | 12,448 | 30,000 | 12,448 | 0 to 12.4 K |
Page: 1